You searched for "blind"
Cutaneous malignant melanoma metastasis to pseudophakic lens
Metastases to the eye and orbit are rare and intraocular cutaneous malignant melanoma metastasis (ICMM) is exceedingly rare, representing around 5%. There have only been three previous cases of ICMM to the lens in the literature, all of which presented...
Differential diagnosis of retinoblastoma and pseudo retinoblastoma
The authors reviewed the rate of pseudo retinoblastoma (PRB) among cases referred for suspicion of RB at a tertiary referral centre in Turkey and the distribution of PRB cases according to age. This was a retrospective study of 549 patients...
Association of sleep problems in children with visual impairment
The intention of this study was to investigate sleep problems in children who had a wide range of visual impairments. Recruitment was via an online survey distributed through the National Federation of Blind and National Organisation for Albinism and Hypopigmentation,...
Pilot trial of Fluoxetine for post-stroke homonymous hemianopia
The authors present a pilot randomised placebo controlled double blind trial assessing 20mg fluoxetine once daily for 90 days versus placebo in stroke survivors with isolated homonymous hemianopia. Exclusion criteria were extensive in terms of pre-existing ophthalmic or neurologic disease,...
Is virtual reality perimetry as reliable as static perimetry in detecting neurological visual field loss?
This study compares agreement between virtual reality perimetry (VRP) and static automated perimetry (SAP) in a variety of neuro-ophthalmological conditions. For this work the Order of Magnitude (OM) VR-based visual field assessment system was used which has been developed by...
Features and associations of CVI in Australian children
The authors report the findings of an audit of data from the Australian Childhood Vision Impairment Register (ACVIR) of 132 Australian children with a primary diagnosis of cerebral visual impairment (CVI). All children were living in Australia, 49% female, 51%...
Could idebenone by the solution for treating dominant optic atrophy?
Dominant optic atrophy (DOA) is a disease of the retinal ganglion cells, with no current treatment options. In most cases, DOA is caused by a mutation in the OPA1 gene. The aim of this study was to evaluate the effect...
